Cost of nosocomial pneumonia: the example of vancomycin versus linezolid—shorter stay or fewer complications?

by Jordi Rello, Cao Bin
Published 2016-10-01

What is the Research Agenda in Ventilator-associated Pneumonia?

by Jordi Rello, Eleonora Bunsow
Published 2016-10-01

Sepsis and septic shock in low-income and middle-income countries: need for a different paradigm

by Jordi Rello, Hakan Leblebicioglu
Published 2016-07-01

Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All

by Grant W. Waterer, Jordi Rello
Published 2020-09-01

Community-acquired bacterial pneumonia in adults: An update

by Vandana Kalwaje Eshwara, Chiranjay Mukhopadhyay, Jordi Rello
Published 2020-01-01

Ventilator-Associated Pneumonia due to Drug-Resistant <i>Acinetobacter baumannii</i>: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In...

by Aušra Čiginskienė, Asta Dambrauskienė, Jordi Rello, Dalia Adukauskienė
Published 2019-02-01

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis

by Roger Sord&amp;eacute;, Albert Pahissa, Jordi Rello
Published 2011-01-01

Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review

by Uğur Önal, Francisco Valenzuela-Sánchez, Kalwaje Eshwara Vandana, Jordi Rello
Published 2018-09-01

Human metapneumovirus as cause of severe community-acquired pneumonia in adults: insights from a ten-year molecular and epidemiological analysis

by Loreto Vidaur, Izarne Totorika, Milagrosa Montes, Diego Vicente, Jordi Rello, Gustavo Cilla
Published 2019-07-01

Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department

by Nuria Angrill, Miguel Gallego, Juli Font, Jordi Vallés, Anisi Morón, Eduard Monsó, Jordi Rello
Published 2020-04-01

Causas de la falta de adherencia a las guías terapéuticas para la neumonía grave

by Simone Gattarello, Sergio Ramírez, José Rafael Almarales, Bárbara Borgatta, Leonel Lagunes, Belén Encina, Jordi Rello
Published 2015-03-01

Management of infections in critically ill returning travellers in the intensive care unit—I: considerations on infection control and transmission of resistance

by Hakan Leblebicioglu, Alfonso J. Rodriguez-Morales, Gian Maria Rossolini, Rogelio López-Vélez, Jean-Ralph Zahar, Jordi Rello
Published 2016-07-01

Management of infections in critically ill returning travellers in the intensive care unit—II: clinical syndromes and special considerations in immunocompromised patients

by Jordi Rello, Oriol Manuel, Philippe Eggimann, Guy Richards, Christian Wejse, Jorgen Eskild Petersen, Kai Zacharowski, Hakan Leblebicioglu
Published 2016-07-01

Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives

by Yinggang Zhu, Antoine Monsel, Jason A. Roberts, Konstantinos Pontikis, Olivier Mimoz, Jordi Rello, Jieming Qu, Jean-Jacques Rouby, on behalf of the European Investigator Network for Nebulized Antibiotics in Ventilator-Associated Pneumonia (ENAVAP)
Published 2021-05-01

Compliance with guidelines-recommended processes in pneumonia: impact of health status and initial signs.

by Rosario Menéndez, Antoni Torres, Soledad Reyes, Rafael Zalacain, Alberto Capelastegui, Olga Rajas, Luis Borderías, Juan J Martín-Villasclaras, Salvador Bello, Inmaculada Alfageme, Felipe Rodríguez de Castro, Jordi Rello, Luis Molinos, Juan Ruiz-Manzano
Published 2012-01-01

Community acquired infections among refugees leading to Intensive Care Unit admissions in Turkey

by Mediha Turktan, Oznur Ak, Hakan Erdem, Dilek Ozcengiz, Sally Hargreaves, Safak Kaya, Emre Karakoc, Ozlem Ozkan-Kuscu, Gunay Tuncer-Ertem, Recep Tekin, Handan Birbicer, Gul Durmus, Canan Yilmaz, Funda Kocak, Edmond Puca, Jordi Rello
Published 2017-05-01

Predictors of Severe Sepsis among Patients Hospitalized for Community-Acquired Pneumonia.

by Beatriz Montull, Rosario Menéndez, Antoni Torres, Soledad Reyes, Raúl Méndez, Rafael Zalacaín, Alberto Capelastegui, Olga Rajas, Luis Borderías, Juan Martin-Villasclaras, Salvador Bello, Inmaculada Alfageme, Felipe Rodríguez de Castro, Jordi Rello, Luis Molinos, Juan Ruiz-Manzano, NAC Calidad Group
Published 2016-01-01

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trial

by Christopher Adlbrecht, Raphael Wurm, Pieter Depuydt, Herbert Spapen, Jose A. Lorente, Thomas Staudinger, Jacques Creteur, Christian Zauner, Andreas Meier-Hellmann, Philipp Eller, Margot Vander Laenen, Zsolt Molnár, István Várkonyi, Bernhard Schaaf, Mária Héjja, Vladimír Šrámek, Hauke Schneider, Niranjan Kanesa-thasan, Susanne Eder-Lingelbach, Anton Klingler, Katrin Dubischar, Nina Wressnigg, Jordi Rello
Published 2020-03-01

What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol

by Clark D Russell, John Amuasi, Jordi Rello, Robert Fowler, Gail Carson, Katrina Hann, Fernando Bozza, Ewen Harrison, Joanne McPeake, Daniel Munblit, Daniel Plotkin, Louise Sigfrid, Antonia Ho, Carlo Palmieri, J Kenneth Baille, Janet T Scott, Hayley Hardwick, Madiha Hashmi, Edwin Jesudason, Jan Cato Holter, Anders Benjamin Kildal, Luis Felipe Reyes, Anna Beltrame, Ibrahim Richard Bangura, Sulaiman Lakoh, Anne Margarita Dyrhol-Riise
Published 2021-03-01

Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status

by Djamel Mokart, Michael Darmon, Peter Schellongowski, Peter Pickkers, Marcio Soares, Jordi Rello, Philippe R. Bauer, Andry van de Louw, Virginie Lemiale, Fabio Silvio Taccone, Ignacio Martin-Loeches, Jorge Salluh, Katerina Rusinova, Sangeeta Mehta, Massimo Antonelli, Achille Kouatchet, Andreas Barratt-Due, Miia Valkonen, Precious Pearl Landburg, Ramin Brandt Bukan, Frédéric Pène, Victoria Metaxa, Gaston Burghi, Colombe Saillard, Lene B. Nielsen, Emmanuel Canet, Magali Bisbal, Elie Azoulay, for the Efraim investigators and the Nine-I study group
Published 2020-10-01